# Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers

> **NCT01620333** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 24 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** biphasic insulin aspart 50
- **DRUG:** biphasic insulin aspart 70

## Key facts

- **NCT ID:** NCT01620333
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** 2000-04
- **Final completion:** 2000-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620333, "Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01620333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*